CD14+ CD16- monocyte

Biomarker

1 paper1 finding

  • In silico1

Effects

1

PhenoAgeAccel

upin humans1

1 study
  1. CD14+ CD16- monocyte increases PhenoAgeAccel in humans (β = 0.41, 95% CI: 0.24-0.58).

    “risk associations of CD14+ CD16− monocyte (β = 0.41, 95% CI:0.24-0.58, PFDR = 6.84 × 10−4)”

    Humans

    Causal effects of immune cell populations on biological aging: a Mendelian randomization study

    Biogerontology15 Nov 2025

More on PhenoAgeAccel

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 2Oct 2026: 05 in 12 months
bioRxiv

Transitional senescent monocytes drive age-related inflammation in humans

Researchers identified a transient senescent-like monocyte state governed by the transcription factor AP-1 that primes cells toward inflammatory and sepsis-associated…Researchers identified a transient senescent-like monocyte state governed by the transcription factor AP-1 that primes cells toward inflammatory and sepsis-associated states.

Preprint: cohort study in peopleCellular senescence